|
Health
Promotion
H1N1 Influenza
H1N1
Influenza
|
NLMA |
Regional Health Authorities |
Government |
Clinical Tools and Resources for
Physicians
NLMA H1N1 Pandemic President's
Letters
H1N1 Pandemic - Bulletin #7
November 9, 2009
A
number of you have contacted the NLMA with questions about accessing
additional personal protective equipment as supplies are depleted in
your offices. The Department of Health, through the regional health
authorities, has made some personal protective equipment available
to physicians’ offices for the care of patients with potential H1N1
influenza illness.
Regional
Health Authority H1N1 Updates
Eastern Health
Antiviral Stockpile Access Discontinued
(PDF)
Posted April 5, 2010 Effective immediately, antiviral medications will no longer be accessible for treatment of H1N1 pandemic influenza. We
do not anticipate a “third wave” of H1N1 pandemic influenza because of the high level of vaccine coverage that has been
achieved in this province and since December there has been little influenza activity across the country. Consequently,
the Department of Health and Community Services will be calling back the stock that has been positioned in pharmacies
and Eastern Health facilities.
Provincial Government Advisories
Mass Immunization Clinics Open to General
Public
November 20, 2009
Effective immediately, all
individuals will be eligible to receive the H1N1 vaccine, the
Honourable Jerome Kennedy, Minister of Health and Community
Services, announced today. Students in Grades 10 to 12 will receive
the vaccine beginning next week within the school system, where
possible.
Clinical Tools and Resources for Physicians
Clinical management of human infection
with pandemic influenza (H1N1) 2009: Revised guidance
(PDF)
Posted November 19, 2009
In October 2009, WHO convened an international
consultation represented by all WHO Regions, in Washington, DC, USA,
to revise the guidance on clinical management of patients with
pandemic (H1N1) 2009 virus infection. Experts in public health,
laboratory science, pathology, and clinical care came together to
review the published evidence to date and to share unpublished data.
This document incorporates the knowledge made available to WHO and
updates previous WHO guidance.
|
